MOLECULAR BIOSCIENCES LAB

BSL-2 · CLIA certified · ISO 15189
Boston, MA Est. 1998 Core facility
47+ active projects
16 research staff
5 core instruments
124 publications (2024)
Research focus & core areas

Functional genomics

CRISPR screens, single-cell transcriptomics, and epigenetic regulation in disease models.

8 active grants

Infectious disease

Host-pathogen interactions, rapid sequencing, and antiviral resistance surveillance.

CDC collaborator

Precision diagnostics

Liquid biopsy, methylation biomarkers, and digital PCR for oncology & rare diseases.

CLIA lab

Neurogenetics

Identifying genetic modifiers of neurodegeneration using iPSC and mouse models.

NIH R01
Key instrumentation
Illumina NovaSeq X High-throughput sequencing · 10B reads/run
10x Genomics Chromium Single-cell isolation & library prep
Thermo Fisher Q Exactive Orbitrap mass spectrometer
ZEISS LSM 980 Confocal with Airyscan 2
Beckman Cytobot Automated high-content screening
Bio-Rad QX600 droplet digital PCR
Principal investigators & leads
ED

Elena De Luca, PhD

Director · Functional genomics

MW

Marcus Weber, MD

Clinical genomics

SC

Sophia Chen, PhD

Proteomics & mass spec

JR

James Rodriguez

Senior bioinformatician

14 additional research fellows, grad students, and technicians

Recent publications
  • 2025
    Single-cell dissection of transcriptional memory in drug-tolerant lung cancer cells.
    Nat. Genetics, Weber et al.
  • 2024
    A multi-omics atlas of host response to M. tuberculosis in alveolar organoids.
    Cell Reports, De Luca, Chen et al.
  • 2024
    Ultrasensitive methylation haplotyping by targeted nanopore sequencing.
    Genome Biol., Rodriguez et al.
  • 2023
    High‑throughput CRISPRi screening identifies novel modulators of tau aggregation.
    Neuron, Chen & Weber

view all publications